临床荟萃

• 荟萃分析 • 上一篇    下一篇

左乙拉西坦预防小儿热性惊厥复发疗效的Meta分析

  

  1. 1. 兰州大学第二医院儿童医院 a.神经消化科;b.小儿重症医学科,甘肃 兰州 730000;2.兰州大学第一临床医学院,甘肃  兰州 730000;
    3.郑州大学第一附属医院 研究生院,河南 郑州 450000;4.甘肃中医药大学 研究生院,甘肃  兰州 730000
  • 出版日期:2016-07-05 发布日期:2016-07-08
  • 通讯作者: 通信作者:张妮,Email:ldeyxxn@163.com

A metaanalysis of levetiracetam on prevention of recurrent febrile seizures in children

  1. 1a.Neurologic and Digestive Department;b.Pediatric Intensive Care Unit, the Children's Hospital of
    Lanzhou University's Second Hospital, Lanzhou 730000,China; 2.The First Clinical Medical College of
    Lanzhou University, Lanzhou 730000,China; 3.Graduate School, the First Hospital of
    Zhengzhou University, Zhengzhou 450000,China; 4.Graduate School, Gansu University of 
    Traditional Chinese Medicine,Lanzhou 730000,China
  • Online:2016-07-05 Published:2016-07-08
  • Contact: Corresponding author: Zhang Ni,Email:ldeyxxn@163.com

摘要: 目的系统评价左乙拉西坦预防小儿热性惊厥复发的有效性与安全性。方法计算机检索PubMed、The Cochrane Library、Embsae、CBM、Wan fang Data、VIP和CNKI数据库,查找关于以左乙拉西坦为干预措施预防小儿热性惊厥复发的随机对照试验,并追查纳入排除文献的参考文献。检索时限均从建库至2016年3月20日。由2名研究者按照纳入与排除标准独立筛选文献、提取资料并评价质量后,采用RevMan 5.2软件进行Meta分析。结果共纳入5个研究,共计475例患者。Meta分析结果显示:与常规退热治疗相比,左乙拉西坦可以明显降低热性惊厥的复发率[RR=0.30,95%CI(0.21,0.43),P<0.01];不能降低癫痫发生率[RR=1.11,95%CI(0.26,4.79),P=0.89];同时会增加不良反应发生率[RR=4.36,95%CI(1.01,18.76),P=0.05]。结论左乙拉西坦在预防小儿热性惊厥复发方面具有较好的疗效,不能降低癫痫发生率,会增加不良反应发生,由于纳入研究存在偏倚可能,尚需更多高质量、多中心、大规模RCT进一步验证。

关键词: 惊厥, 发热性;左乙拉西坦;评价研究;Meta分析

Abstract: Objective  To systematically review the clinical efficacy and security of levetiracetam reducing the recurrence rate of febrile seizures. Methods  Databases such as PubMed, Cochrane Library, Embase, CBM, Wan fang Data, VIP and CNKI were searched  in levetiracetam as interventions in the treatment of febrile seizures from inception to March 20th, 2016. Literature screening, extracting data and evaluating methodological quality were independently performed by two reviewers. Metaanalysis was conducted using RevMan 5.2 software. Results  A total of 5 studies involving 475 patients were included. Metaanalysis showed that compared with conventional method of antifebrile, levetiracetam can significantly reduce the recurrence rate of febrile seizures than the conventional antifebrile method (RR=0.30, 95%CI[0.21,0.43],P<0.01); but can not reduce the incidence rate of epilepsy (RR=1.11, 95%CI[0.26,4.79],P=0.89); and can increase the incidence rate of adverse reactions (RR=4.36, 95%CI[1.01,18.76],P=0.05). Conclusion  Levetiracetam can significantly reduce the recurrence rate of febrile seizures, and can not reduce the rate of epilepsy, but  increase the incidence of adverse reactions.

Key words: seizures, febrile, levetiracetam, evaluation studies, metaanalysis